Barzon L - Search Results

1

Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'.

Lavezzo E, Franchin E, Ciavarella C, Cuomo-Dannenburg G, Barzon L, Del Vecchio C, Rossi L, Manganelli R, Loregian A, Navarin N, Abate D, Sciro M, Merigliano S, De Canale E, Vanuzzo MC, Besutti V, Saluzzo F, Onelia F, Pacenti M, Parisi SG, Carretta G, Donato D, Flor L, Cocchio S, Masi G, Sperduti A, Cattarino L, Salvador R, Nicoletti M, Caldart F, Castelli G, Nieddu E, Labella B, Fava L, Drigo M, Gaythorpe KAM; Imperial College COVID-19 Response Team; Brazzale AR, Toppo S, Trevisan M, Baldo V, Donnelly CA, Ferguson NM, Dorigatti I, Crisanti A; Imperial College COVID-19 Response Team. Lavezzo E, et al. Among authors: barzon l. Nature. 2020 Aug;584(7821):425-429. doi: 10.1038/s41586-020-2488-1. Epub 2020 Jun 30. Nature. 2020. PMID: 32604404

2

Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase.

Barzon L, Bonaguro R, Castagliuolo I, Chilosi M, Franchin E, Del Vecchio C, Giaretta I, Boscaro M, Palù G. Barzon L, et al. Eur J Endocrinol. 2003 Jan;148(1):73-80. doi: 10.1530/eje.0.1480073. Eur J Endocrinol. 2003. PMID: 12534360

3

Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse.

Barzon L, Boscaro M, Pacenti M, Taccaliti A, Palù G. Barzon L, et al. Int J Cancer. 2004 Jul 20;110(6):914-20. doi: 10.1002/ijc.20182. Int J Cancer. 2004. PMID: 15170676 Free article.

4

Gene therapy for thyroid cancer.

Barzon L, Pacenti M, Boscaro M, Palù G. Barzon L, et al. Expert Opin Biol Ther. 2004 Aug;4(8):1225-39. doi: 10.1517/14712598.4.8.1225. Expert Opin Biol Ther. 2004. PMID: 15268658 Review.

5

A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma.

Barzon L, Pacenti M, Taccaliti A, Franchin E, Bruglia M, Boscaro M, Palù G. Barzon L, et al. J Clin Endocrinol Metab. 2005 May;90(5):2831-4. doi: 10.1210/jc.2004-2139. Epub 2005 Feb 15. J Clin Endocrinol Metab. 2005. PMID: 15713704

6

Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results.

Colombo F, Barzon L, Franchin E, Pacenti M, Pinna V, Danieli D, Zanusso M, Palù G. Colombo F, et al. Among authors: barzon l. Cancer Gene Ther. 2005 Oct;12(10):835-48. doi: 10.1038/sj.cgt.7700851. Cancer Gene Ther. 2005. PMID: 15891772 Clinical Trial.

7

Versatility of gene therapy vectors through viruses.

Barzon L, Stefani AL, Pacenti M, Palù G. Barzon L, et al. Expert Opin Biol Ther. 2005 May;5(5):639-62. doi: 10.1517/14712598.5.5.639. Expert Opin Biol Ther. 2005. PMID: 15934840 Review.

8

Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.

Barzon L, Pacenti M, Masi G, Stefani AL, Fincati K, Palù G. Barzon L, et al. Oncology. 2005;68(4-6):414-21. doi: 10.1159/000086983. Epub 2005 Jul 12. Oncology. 2005. PMID: 16020971

9

Detection of polyomaviruses and herpesviruses in human adrenal tumors.

Barzon L, Trevisan M, Masi G, Pacenti M, Sinigaglia A, Macchi V, Porzionato A, De Caro R, Favia G, Iacobone M, Palù G. Barzon L, et al. Oncogene. 2008 Jan 31;27(6):857-64. doi: 10.1038/sj.onc.1210699. Epub 2007 Aug 6. Oncogene. 2008. PMID: 17684484

10

The role of 21-hydroxylase in the pathogenesis of adrenal masses: review of the literature and focus on our own experience.

Barzon L, Maffei P, Sonino N, Pilon C, Baldazzi L, Balsamo A, Del Maschio O, Masi G, Trevisan M, Pacenti M, Fallo F. Barzon L, et al. J Endocrinol Invest. 2007 Jul-Aug;30(7):615-23. doi: 10.1007/BF03346358. J Endocrinol Invest. 2007. PMID: 17848847 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page